UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 56

Sortiert nach

A Subunit Cytomegalovirus Vaccine Based on Recombinant Envelope Glycoprotein B and a New Adjuvant

The Journal of infectious diseases, 1999-10, Vol.180 (4), p.970-975

1999

Volltextzugriff (PDF)

Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: A randomized controlled trial

JAMA : the journal of the American Medical Association, 2000-07, Vol.284 (2), p.183

2000

Volltextzugriff (PDF)

Clade B-Based HIV-1 Vaccines Elicit Cross-Clade Cytotoxic T Lymphocyte Reactivities in Uninfected Volunteers

Proceedings of the National Academy of Sciences - PNAS, 1997-02, Vol.94 (4), p.1396-1401

1997

Volltextzugriff (PDF)

Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers

AIDS (London), 1998-12, Vol.12 (18), p.2407-2415

1998

Volltextzugriff (PDF)

Safety of 2 Recombinant Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Vaccines in Neonates Born to HIV-1-Infected Women

Clinical infectious diseases, 2001-03, Vol.32 (5), p.801-807

2001

Volltextzugriff (PDF)

Effects of Antigen Dose and Immunization Regimens on Antibody Responses to a Cytomegalovirus Glycoprotein B Subunit Vaccine

The Journal of infectious diseases, 1999-11, Vol.180 (5), p.1700-1703

1999

Volltextzugriff (PDF)

Human Immunodeficiency Virus Type 1 (HIV-1) gp120–Specific Antibodies in Neonates Receiving an HIV-1 Recombinant gp120 Vaccine

The Journal of infectious diseases, 2001-11, Vol.184 (10), p.1331-1335

2001

Volltextzugriff (PDF)

High risk of HIV-1 infection for first-born twins

The Lancet (British edition), 1991-12, Vol.338 (8781), p.1471-1475

1991

Volltextzugriff (PDF)

A Human Immunodeficiency Virus Prime-Boost Immunization Regimen in Humans Induces Antibodies That Show Interclade Cross-Reactivity and Neutralize Several X4-, R5-, and Dualtropic Clade B and C Primary Isolates

Journal of Virology, 2000-11, Vol.74 (21), p.10025-10033

2000

Volltextzugriff (PDF)

Neutralization of a Clade B Primary Isolate by Sera from Human Immunodeficiency Virus-Uninfected Recipients of Candidate AIDS Vaccines

The Journal of infectious diseases, 1997-04, Vol.175 (4), p.764-774

1997

Volltextzugriff (PDF)

Induction of HIV-1-neutralising and syncytium-inhibiting antibodies in uninfected recipients of HIV-1IIIB rgp120 subunit vaccine

The Lancet (British edition), 1993-07, Vol.342 (8863), p.69-73

1993

Volltextzugriff (PDF)

Safety and Immunogenicity of a Canarypox-Vectored Human Immunodeficiency Virus Type 1 Vaccine with or without gp120: A Phase 2 Study in Higher- and Lower-Risk Volunteers

The Journal of infectious diseases, 2001-05, Vol.183 (9), p.1343-1352

2001

Volltextzugriff (PDF)

Mucosal Antibodies to Human Cytomegalovirus Glycoprotein B Occur following both Natural Infection and Immunization with Human Cytomegalovirus Vaccines

The Journal of infectious diseases, 1996-08, Vol.174 (2), p.387-392

1996

Volltextzugriff (PDF)

Effect of Previous or Simultaneous Immunization with Canarypox Expressing Cytomegalovirus (CMV) Glycoprotein B (gB) on Response to Subunit gB Vaccine plus MF59 in Healthy CMV-Seronegative Adults

The Journal of infectious diseases, 2002-03, Vol.185 (5), p.686-690

2002

Volltextzugriff (PDF)

Safety and Immunogenicity of Combinations of Recombinant Subtype E and B Human Immunodeficiency Virus Type 1 Envelope Glycoprotein 120 Vaccines in Healthy Thai Adults

The Journal of infectious diseases, 2003-07, Vol.188 (2), p.219-227

2003

Volltextzugriff (PDF)

Natural history of human immunodeficiency virus type 1 infection in children : prognostic value of laboratory tests on the bimodal progression of the disease

The Pediatric infectious disease journal, 1992-08, Vol.11 (8), p.630-635

1992

Volltextzugriff (PDF)

Clinical, immunologic, and virologic observations related to human immunodeficiency virus (HIV) type 1 infection in a volunteer in an HIV-1 vaccine clinical trial

The Journal of infectious diseases, 1995-05, Vol.171 (5), p.1343

1995

Volltextzugriff (PDF)

Neutralization of Syncytium-Inducing Primary Isolates by Sera from Human Immunodeficiency Virus (HIV)-Uninfected Recipients of Candidate HIV Vaccines

The Journal of infectious diseases, 1998-11, Vol.178 (5), p.1502-1506

1998

Volltextzugriff (PDF)

A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative Thais

Vaccine, 2000-02, Vol.18 (15), p.1448-1455

2000

Volltextzugriff (PDF)

Antibodies to the Major Linear Neutralizing Domains of Cytomegalovirus Glycoprotein B Among Natural Seropositives and CMV Subunit Vaccine Recipients

Viral immunology, 2000-01, Vol.13 (3), p.329-341

2000

Volltextzugriff (PDF)

Lymphoproliferative Responses to Recombinant HIV-1 Envelope Antigens in Neonates and Infants Receiving gp120 Vaccines

The Journal of infectious diseases, 2000-03, Vol.181 (3), p.890-896

2000

Volltextzugriff (PDF)

Vaccination of Seropositive Subjects with CHIRON CMV gB Subunit Vaccine Combined with MF59 Adjuvant for Production of CMV Immune Globulin

Viral immunology, 2000, Vol.13 (1), p.49-56

2000

Volltextzugriff (PDF)

Specific antibody responses to vaccination with bivalent CM235/SF2 gp120: Detection of homologous and heterologous neutralizing antibody to subtype E (CRF01.AE) HIV type 1

AIDS research and human retroviruses, 2003-09, Vol.19 (9), p.807-816

2003

Volltextzugriff (PDF)

A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk for acquiring HIV type 1 infection

AIDS research and human retroviruses, 2000-06, Vol.16 (9), p.907-919

2000

Volltextzugriff (PDF)

CD4 immunoadhesins in anti-HIV therapy: new developments

International journal of cancer, 1992, Vol.7 (suppl. 7), p.69-72

1992

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(56)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(38)
Science & Technology
(33)
Life Sciences & Biomedicine
(32)
Biological And Medical Sciences
(28)
Female
(25)
Aids/hiv
(23)
Male
(23)
Immunology
(22)
Infectious Diseases
(22)
Adult
(21)
Medical Sciences
(19)
Virology
(18)
Microbiology
(17)
Aids Vaccines - Immunology
(16)
Hiv Envelope Protein Gp120 - Immunology
(15)
Middle Aged
(14)
Vaccination
(14)
Fundamental And Applied Biological Sciences. Psychology
(13)
Hiv
(13)
Hiv-1 - Immunology
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Subunit Cytomegalovirus Vaccine Based on Recombinant Envelope Glycoprotein B and a New Adjuvant

Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: A randomized controlled trial

Clade B-Based HIV-1 Vaccines Elicit Cross-Clade Cytotoxic T Lymphocyte Reactivities in Uninfected Volunteers

Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers

Safety of 2 Recombinant Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Vaccines in Neonates Born to HIV-1-Infected Women

Effects of Antigen Dose and Immunization Regimens on Antibody Responses to a Cytomegalovirus Glycoprotein B Subunit Vaccine

Human Immunodeficiency Virus Type 1 (HIV-1) gp120–Specific Antibodies in Neonates Receiving an HIV-1 Recombinant gp120 Vaccine

High risk of HIV-1 infection for first-born twins

A Human Immunodeficiency Virus Prime-Boost Immunization Regimen in Humans Induces Antibodies That Show Interclade Cross-Reactivity and Neutralize Several X4-, R5-, and Dualtropic Clade B and C Primary Isolates

Neutralization of a Clade B Primary Isolate by Sera from Human Immunodeficiency Virus-Uninfected Recipients of Candidate AIDS Vaccines

Induction of HIV-1-neutralising and syncytium-inhibiting antibodies in uninfected recipients of HIV-1IIIB rgp120 subunit vaccine

Safety and Immunogenicity of a Canarypox-Vectored Human Immunodeficiency Virus Type 1 Vaccine with or without gp120: A Phase 2 Study in Higher- and Lower-Risk Volunteers

Mucosal Antibodies to Human Cytomegalovirus Glycoprotein B Occur following both Natural Infection and Immunization with Human Cytomegalovirus Vaccines

Effect of Previous or Simultaneous Immunization with Canarypox Expressing Cytomegalovirus (CMV) Glycoprotein B (gB) on Response to Subunit gB Vaccine plus MF59 in Healthy CMV-Seronegative Adults

Safety and Immunogenicity of Combinations of Recombinant Subtype E and B Human Immunodeficiency Virus Type 1 Envelope Glycoprotein 120 Vaccines in Healthy Thai Adults

Natural history of human immunodeficiency virus type 1 infection in children : prognostic value of laboratory tests on the bimodal progression of the disease

Clinical, immunologic, and virologic observations related to human immunodeficiency virus (HIV) type 1 infection in a volunteer in an HIV-1 vaccine clinical trial

Neutralization of Syncytium-Inducing Primary Isolates by Sera from Human Immunodeficiency Virus (HIV)-Uninfected Recipients of Candidate HIV Vaccines

A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative Thais

Antibodies to the Major Linear Neutralizing Domains of Cytomegalovirus Glycoprotein B Among Natural Seropositives and CMV Subunit Vaccine Recipients

Lymphoproliferative Responses to Recombinant HIV-1 Envelope Antigens in Neonates and Infants Receiving gp120 Vaccines

Vaccination of Seropositive Subjects with CHIRON CMV gB Subunit Vaccine Combined with MF59 Adjuvant for Production of CMV Immune Globulin

Specific antibody responses to vaccination with bivalent CM235/SF2 gp120: Detection of homologous and heterologous neutralizing antibody to subtype E (CRF01.AE) HIV type 1

A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk for acquiring HIV type 1 infection

CD4 immunoadhesins in anti-HIV therapy: new developments

Suchergebnisse filtern